Výsledky vyhledávání - "Eleanor Gomez-Fein"

Multicenter Evaluation of Risk Factors for Aspergillosis in Patients Treated with Lipid Amphotericin B Products: Outcomes, Drug Utilization Parameters, and Benchmarking

Autor: Ambarish Ambegaonkar, John Papadopoulos, Shawn Scott Sutton, John Cazes, Joel Hennenfent, Teresa J. Lubowski, Eleanor Gomez-Fein, Ali J. Olyaei

Publikováno v: Hospital Pharmacy. 38:232-240

Purpose To evaluate the use of lipid amphotericin B products in relation to risk factors for aspergillosis and candidemia at the time therapy was initiated. Methods A single-group, concurrent, observational, multicenter study in hospitalized patients

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1340e9a237b79d234c3ee10a81f7b88b
https://doi.org/10.1177/001857870303800315

Zobrazit plný text záznamu

Bioavailability of oral fluconazole in critically ill abdominal trauma patients with and without abdominal wall closure: a randomized crossover clinical trial

Autor: Ernest F. J. Block, Gary R. Collin, Eleanor Gomez-Fein, Heythem Alzamel, Erik Barquist, Octavio Martinez

Publikováno v: The Journal of trauma. 63(1)

Patients with non-apposed fascial edges, known as laparostomy patients, have traditionally been given intravenous medications, because enteral absorption of medications was thought to be unpredictable. We hypothesized that critically ill patients wit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fba55d2f9eed9eccb5e98ead0f4f12d2
https://pubmed.ncbi.nlm.nih.gov/17622884

Zobrazit plný text záznamu

Early injection of high-dose recombinant factor VIIa decreases blood loss and prolongs time from injury to death in experimental liver injury

Autor: Marlies Ledford, Eleanor Gomez-Fein, Qammar Rashid, Dory D. Jewelewicz, Mauricio Lynn, Igor Jeroukhimov, Jana B.A. MacLeod, Julia Zaias, George T. Hensley, Francisco G. Pernas, Stephen M. Cohn

Publikováno v: The Journal of trauma. 53(6)

Background: Recombinant factor VIIa (rFVIIa) is used for treatment of bleeding episodes in hemophilia patients who develop inhibitors to factors VIII and IX. We tested the hypothesis that administration of rFVIIa early after injury would decrease ble

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00de3e6b9ef05529294adb40475f2d1a
https://pubmed.ncbi.nlm.nih.gov/12478027

Zobrazit plný text záznamu

Akademický článek

Early Injection of High-Dose Recombinant Factor VIIa Decreases Blood Loss and Prolongs Time from Injury to Death in Experimental Liver Injury.

Autor: Igor Jeroukhimov, Dory Jewelewicz, Julia Zaias, George Hensley, Jana MacLeod, Stephen M. Cohn, Qammar Rashid, Francisco Pernas, Marlies R. Ledford, Eleanor Gomez-Fein, Mauricio Lynn

Publikováno v: Journal of Trauma; 2002 Dec, Vol. 53 Issue 6, p1053-1057, 5p

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání